Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001611506-14-000001
Filing Date
2014-06-26
Accepted
2014-06-26 18:30:31
Documents
1
Period of Report
2014-06-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1733
  Complete submission text file 0001611506-14-000001.txt   3232
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Issuer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 1240 SUGG PARKWAY GREENVILLE NC 27834
Business Address
Cross Stefan (Reporting) CIK: 0001611506 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13467 | Film No.: 14943732